Benchmarks › Pathology and Laboratory
Pathology and Laboratory: Federal IDR benchmarks
In 2025-Q4 the median prevailing offer for Pathology and Laboratory (CPT 0001U - 0475U, 80047 - 89398) was 440% of the QPA, across 31,977 payment determinations covering 146,908 items or services.
| Quarter | Median prevailing offer, % of QPA | Determinations | Items or services |
|---|---|---|---|
| 2025-Q1 | 470% | 15,006 | 69,389 |
| 2025-Q2 | 450% | 26,623 | 117,337 |
| 2025-Q3 | 452% | 37,894 | 175,184 |
| 2025-Q4 | 440% | 31,977 | 146,908 |
Source: CMS Federal IDR Supplemental Tables, reporting year 2025 (CMS reports page). Quarterly medians cannot be combined into a yearly median, so each quarter is shown separately.
What this does and does not tell you
A median describes the middle of past outcomes for the whole specialty. It is not a prediction for a specific claim: the QPA band, the plan, the state, the evidence you submit and the entity all matter. Lower-QPA items tend to see higher multiples; see QPA bands.
Estimate a claim in this specialty
Get the next quarterly update
We are building a flat-fee tracker for eligibility, deadlines, batches and payment follow-up. Join the list and we will email you when it opens. No patient information needed.